Literature DB >> 31343700

Low Back Pain--Related Disability in Parkinson Disease: Impact on Functional Mobility, Physical Activity, and Quality of Life.

Ryan P Duncan1,2, Linda R Van Dillen3, Jane M Garbutt4, Gammon M Earhart5, Joel S Perlmutter6.   

Abstract

BACKGROUND: People with Parkinson disease (PD) frequently experience low back pain (LBP), yet the impact of LBP on functional mobility, physical activity, and quality of life (QOL) has not been described in PD.
OBJECTIVE: The objectives of this study were to describe body positions and functional activities associated with LBP and to determine the relationships between LBP-related disability and PD motor sign severity, physical activity level, and QOL.
DESIGN: The study was a cross-sectional study.
METHODS: Thirty participants with idiopathic PD (mean age = 64.6 years [SD = 10.3]; 15 women) completed the Revised Oswestry Disability Questionnaire (RODQ), a measure of LBP-related disability. PD motor symptom severity was measured using the Movement Disorder Society-Unified Parkinson Disease Rating Scale Part III (MDS-UPRDS III). The Physical Activity Scale for the Elderly (PASE) was used to measure self-reported physical activity. The Parkinson Disease Questionnaire-39 (PDQ-39) was used to measure QOL. Descriptive statistics were used to characterize LBP intensity and LBP-related disability. Spearman correlations were used to determine relationships between the RODQ and the MDS-UPDRS III, PASE, and PDQ-39.
RESULTS: LBP was reported to be of at least moderate intensity by 63.3% of participants. LBP most frequently impaired standing, sleeping, lifting, and walking. The RODQ was significantly related to the MDS-UPDRS III (r = 0.38), PASE (r = -0.37), PDQ-39 summary index (r = 0.55), PDQ-39 mobility subdomain (r = 0.54), and PDQ-39 bodily pain subdomain (r = 0.44). LIMITATIONS: Limitations included a small sample of people with mild to moderate PD severity, the fact that RODQ is a less frequently used measure of LBP-related disability, and the lack of a non-PD control group.
CONCLUSIONS: LBP affected walking, sleeping, standing, and lifting in this small sample of people with mild to moderate PD. Greater LBP-related disability was associated with greater motor sign severity, lower physical activity level, and lower QOL in people with PD.
© 2019 American Physical Therapy Association.

Entities:  

Mesh:

Year:  2019        PMID: 31343700      PMCID: PMC6821152          DOI: 10.1093/ptj/pzz094

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  31 in total

Review 1.  Musculoskeletal problems in Parkinson's disease.

Authors:  Young Eun Kim; Beom S Jeon
Journal:  J Neural Transm (Vienna)       Date:  2013-02-19       Impact factor: 3.575

Review 2.  The effect of lifting during work on low back pain: a health impact assessment based on a meta-analysis.

Authors:  Pieter Coenen; Vincent Gouttebarge; Aafje S A M van der Burght; Jaap H van Dieën; Monique H W Frings-Dresen; Allard J van der Beek; Alex Burdorf
Journal:  Occup Environ Med       Date:  2014-08-27       Impact factor: 4.402

3.  The clinical course of pain and function in older adults with a new primary care visit for back pain.

Authors:  Sean D Rundell; Karen J Sherman; Patrick J Heagerty; Charles N Mock; Jeffrey G Jarvik
Journal:  J Am Geriatr Soc       Date:  2015-03-06       Impact factor: 5.562

4.  Transient low back pain development during standing predicts future clinical low back pain in previously asymptomatic individuals.

Authors:  Erika Nelson-Wong; Jack P Callaghan
Journal:  Spine (Phila Pa 1976)       Date:  2014-03-15       Impact factor: 3.468

Review 5.  The association between chronic low back pain and sleep: a systematic review.

Authors:  Gráinne A Kelly; Catherine Blake; Camillus K Power; Declan O'keeffe; Brona M Fullen
Journal:  Clin J Pain       Date:  2011-02       Impact factor: 3.442

Review 6.  Description of Parkinson's disease as a clinical syndrome.

Authors:  Stanley Fahn
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

7.  Lumbar Mobility and Performance-Based Function: An Investigation in Older Adults with and without Chronic Low Back Pain.

Authors:  Peter C Coyle; Teonette Velasco; J Megan Sions; Gregory E Hicks
Journal:  Pain Med       Date:  2017-01-01       Impact factor: 3.750

8.  Risk factors for more severe regional musculoskeletal symptoms: a two-year prospective study of a general working population.

Authors:  Johan H Andersen; Jens P Haahr; Poul Frost
Journal:  Arthritis Rheum       Date:  2007-04

9.  Characteristics and exacerbating factors of chronic low back pain in Parkinson's disease.

Authors:  Kei Watanabe; Toru Hirano; Keiichi Katsumi; Masayuki Ohashi; Atsushi Ishikawa; Ryoko Koike; Naoto Endo; Masatoyo Nishizawa; Takayoshi Shimohata
Journal:  Int Orthop       Date:  2015-10-06       Impact factor: 3.075

Review 10.  Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2015-06-07       Impact factor: 202.731

View more
  4 in total

Review 1.  Musculoskeletal pain in Parkinson's disease: a narrative review.

Authors:  Lauren Elizabeth Tueth; Ryan P Duncan
Journal:  Neurodegener Dis Manag       Date:  2021-08-19

Review 2.  The Role of Mental Imagery in Parkinson's Disease Rehabilitation.

Authors:  Amit Abraham; Ryan P Duncan; Gammon M Earhart
Journal:  Brain Sci       Date:  2021-02-02

3.  Musculoskeletal Pain in Parkinson's Disease.

Authors:  Jun Li; Ben-Fan Zhu; Zhu-Qin Gu; Hui Zhang; Shan-Shan Mei; Shao-Zhen Ji; Shu-Ying Liu; Chao Han; Huai-Zhen Chen; Piu Chan
Journal:  Front Neurol       Date:  2022-01-21       Impact factor: 4.003

4.  A Survey of People With Parkinson's and Their Carers: The Management of Pain in Parkinson's.

Authors:  Jenni Naisby; Anneesa Amjad; Natasha Ratcliffe; Alison J Yarnall; Lynn Rochester; Richard Walker; Katherine Baker
Journal:  J Geriatr Psychiatry Neurol       Date:  2021-07-08       Impact factor: 2.718

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.